SEARLE & CO. - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 2 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SEARLE & CO. ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$63,940
-40.5%
13,9000.0%0.02%
-33.3%
Q2 2023$107,447
+14.0%
13,9000.0%0.03%
+6.5%
Q1 2023$94,242
-33.1%
13,9000.0%0.03%
-35.4%
Q4 2022$140,807
+2.8%
13,9000.0%0.05%
-9.4%
Q3 2022$137,000
-7.4%
13,9000.0%0.05%
-8.6%
Q2 2022$148,000
+8.8%
13,9000.0%0.06%
+16.0%
Q1 2022$136,000
-31.7%
13,9000.0%0.05%
-30.6%
Q4 2021$199,00013,9000.07%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DCVC Bio GP, LLC 29,411$313,000100.00%
Founders Fund VII Management, LLC 3,773,530$40,188,00093.02%
Gruss & Co., LLC 363,778$3,874,00026.99%
Founders Fund Growth Management, LLC 407,017$4,334,00012.66%
GUARDIAN CAPITAL ADVISORS LP 3,836,414$44,387,0005.09%
HARVARD MANAGEMENT CO INC 4,105,095$43,719,0005.06%
Intellectus Partners, LLC 1,089,755$11,606,0003.99%
ArchPoint Investors 630,326$6,713,0002.66%
BRANDYWINE MANAGERS, LLC 56,976$607,0001.49%
Orbimed Advisors 4,180,768$44,525,0000.81%
View complete list of ABCELLERA BIOLOGICS INC shareholders